Signaling pathways
-
BA2682 GGFG-EribulinSummary: GGFG-Eribulin is an ADC-drug linker coupler. -
BA2683 PDS-MMAESummary: PDS-MMAE is modified MMAE. -
BA2684 OH-Glu-Val-Cit-PAB-MMAESummary: OH-Glu-Val-Cit-PAB-MMAE consists of a cleavable ADC linker (OH-Glu-Val-Cit-PAB) and a potent microtubule protein inhibitor (MMAE). -
BA2685 MC-EVCit-PAB-MMAESummary: MC-EVCit-PAB-MMAE (Linker-Payload11) is an ADC (drug-linkerconjugates>. -
BA2686 Mal-Phe-C4-VC-PAB-MMAESummary: Mal-Phe-C4-VC-PAB-MMAE is made from MMAE coupled to Mal-Phe-C4-VC-PAB joints. -
BA2687 TAM558Summary: TAM558 is the payload molecule used to synthesize OMTX705. -
BA2690 DBCO-PEG4-MMAFSummary: DBCO-PEG4-MMAF is part of an antibody-coupled active molecule consisting of MMAF, an inhibitor of microtubule protein polymerization, and degradable DBCO-PEG4. -
BA2691 Mc-Alanyl-Alanyl-Asparagine-PAB-MMAESummary: Mc-Alanyl-Asparagine-PAB-MMAE is a potent anticancer agent (agent) that is specifically activated by the tumor microenvironment. -
BA2692 Val-Cit-PAB-ExatecanSummary: Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) is part of an antibody-activator coupling. -
BA2693 AcLys-PABC-VC-Aur0101Summary: AcLys-PABC-VC-Aur0101 is part of an antibody-coupled active molecule (anti-ADC).

